Osman I M, Godden D J, Friend J A, Legge J S, Douglas J G
Thoracic Medicine Unit, Aberdeen Royal Hospitals Trust, UK.
Thorax. 1997 Jan;52(1):67-71. doi: 10.1136/thx.52.1.67.
There is some evidence that quality of life (QOL) in patients with chronic obstructive pulmonary disease (COPD) may predict clinical outcomes and use of resources. This study examined whether QOL scores could prospectively predict re-admission for COPD or death within 12 months of an original admission, and whether QOL scores predicted home nebuliser provision.
The study was carried out in all acute medical wards of Aberdeen Royal Infirmary, Woodend and City Hospitals, Aberdeen over 12 months. A total of 377 patients admitted with an exacerbation of COPD were identified in this time, 111 of whom were not included in the study because they refused the interview or died before discharge. The remaining 266 patients completed the St George's Respiratory Questionnaire (SGRQ). Information on spirometric parameters, nebuliser provision at discharge, provision of domiciliary oxygen, and re-admission within 12 months was collected from patient notes.
The mean age of the patients was 68 years and 53% were men. The mean (SD) forced expiratory volume in one second (FEV1) was 38.8 (18.0)% predicted and forced vital capacity (FVC) was 58.9 (23.8)% predicted. Higher (worse) scores on the SGRQ were significantly related to re-admission for COPD in the next 12 months (difference = 4.8, 95% CI 1.6 to 8.0). Patients who were re-admitted and died from COPD did not differ in SGRQ scores from those who were re-admitted and survived for more than 12 months. Re-admission was not related to sex, age, or pulmonary function. One hundred and thirty eight patients did not have a home nebuliser before admission. Of these, 14 were provided with a home nebuliser at discharge. Patients provided with nebulisers had significantly worse SGRQ scores and worse FVC. The 41 patients given domiciliary oxygen did not differ in SGRQ or spirometric parameters. Logistic regression analysis of the three SGRQ subscales (Symptom, Impact and Activity), adjusting for lung function, age and sex, showed that all three subscales were significantly related to hospital readmission and that Impact scores were related to nebuliser provision. Women did not differ from men in Symptom scores on the SGRQ but differed markedly on the Activity and Impact scales.
It is concluded that poor scores on the SGRQ, a QOL scale which measures patient distress and coping, are associated with re-admission for COPD and use of resources such as nebulisers, independent of physiological measures of disease severity.
有证据表明,慢性阻塞性肺疾病(COPD)患者的生活质量(QOL)可能预测临床结局和资源利用情况。本研究旨在探讨QOL评分能否前瞻性地预测因COPD再次入院或在首次入院后12个月内死亡,以及QOL评分是否能预测家庭雾化器的配备情况。
本研究在阿伯丁皇家医院、伍登医院和阿伯丁市医院的所有急性内科病房进行,为期12个月。在此期间,共确定了377例因COPD急性加重入院的患者,其中111例因拒绝访谈或在出院前死亡而未纳入研究。其余266例患者完成了圣乔治呼吸问卷(SGRQ)。从患者病历中收集了肺功能参数、出院时雾化器配备情况、家庭氧疗情况以及12个月内再次入院的信息。
患者的平均年龄为68岁,53%为男性。一秒用力呼气容积(FEV1)的平均(标准差)预测值为38.8(18.0)%,用力肺活量(FVC)的平均(标准差)预测值为58.9(23.8)%。SGRQ得分越高(越差)与未来12个月内因COPD再次入院显著相关(差异=4.8,95%可信区间1.6至8.0)。因COPD再次入院并死亡的患者与再次入院并存活超过12个月的患者在SGRQ得分上没有差异。再次入院与性别、年龄或肺功能无关。138例患者入院前没有家庭雾化器。其中,14例在出院时配备了家庭雾化器。配备雾化器的患者SGRQ得分显著更差,FVC也更差。接受家庭氧疗的41例患者在SGRQ或肺功能参数方面没有差异。对SGRQ三个子量表(症状、影响和活动)进行逻辑回归分析,并对肺功能、年龄和性别进行校正,结果显示所有三个子量表均与再次入院显著相关,且影响得分与雾化器配备相关。女性在SGRQ症状得分上与男性没有差异,但在活动和影响量表上有显著差异。
得出结论,SGRQ是一种衡量患者痛苦和应对能力的QOL量表,其得分较低与因COPD再次入院以及雾化器等资源的使用相关,且独立于疾病严重程度的生理指标。